Previous 10 | Next 10 |
Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, to develop multiple...
Summary General Electric successfully spun off GE HealthCare Technologies, resulting in one publicly-traded company turning into two. Though the transformation for General Electric is not complete, this does set up investors for tremendous upside potential. GE HealthCare Industries ...
Agilent Technologies ( NYSE: A ) has acquired Avida Biomed giving the diagnostics and applied chemicals company access to genomic tools that support cancer research. Agilent ( A ) said that Avida's products complement its own SureSelect portfolio and and advance its strategy to ...
Agilent Technologies ( NYSE: A ) said on Wednesday it will acquire Avida Biomed to expand into clinical research and diagnostics markets for cancer research. Avida Biomed is an early-stage life sciences company that develops target enrichment workflows for clinical resea...
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-per...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend C...
Summary Volatility remained elevated as Domestic equities struggled to find direction during the recent period. Investor optimism waned throughout the course of the Period as unrest in China renewed concerns relating to supply chain issues and global growth prospects. The top detrac...
Summary All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8% and a median increase of 5.4%. There are twenty-five increases for next week, up from seven last week. Merry Christma...
In this episode of the Motley Fool Money podcast, Motley Fool senior analyst Bill Mann discusses: Also, Motley Fool producer Ricky Mulvey talks with Jack Caporal from The Ascent, a personal finance brand of The Motley Fool , about the most popular financial New Year's resolutions and ...
The U.S. Food and Drug Administration (FDA) approved Agilent Technologies' ( NYSE: A ) Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to Mirati Therapeutics ( NASDAQ: MRTX ) Krazati which was approved yesterday to treat certain patients with non-small cell ...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast,...